• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疑似多发性硬化症的鉴别诊断:北美、北欧和澳大拉西亚少数族裔和种族背景人群的考虑因素。

Differential diagnosis of suspected multiple sclerosis: considerations in people from minority ethnic and racial backgrounds in North America, northern Europe, and Australasia.

机构信息

University of Southern California (USC), Keck School of Medicine, Department of Neurology, Los Angeles, CA, USA.

Division of Neurology, Department of Medicine, University of Toronto, ON, Canada; St Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada.

出版信息

Lancet Neurol. 2024 Oct;23(10):1050-1062. doi: 10.1016/S1474-4422(24)00288-6.

DOI:10.1016/S1474-4422(24)00288-6
PMID:39304244
Abstract

The differential diagnosis of suspected multiple sclerosis has been developed using data from North America, northern Europe, and Australasia, with a focus on White populations. People from minority ethnic and racial backgrounds in regions where prevalence of multiple sclerosis is high are more often negatively affected by social determinants of health, compared with White people in these regions. A better understanding of changing demographics, the clinical characteristics of people from minority ethnic or racial backgrounds, and the social challenges they face might facilitate equitable clinical approaches when considering a diagnosis of multiple sclerosis. Neuromyelitis optica, systemic lupus erythematous, neurosarcoidosis, infections, and cerebrovascular conditions (eg, hypertension) should be considered in the differential diagnosis of multiple sclerosis for people from minority ethnic and racial backgrounds in North America, northern Europe, and Australasia. The diagnosis of multiple sclerosis in people from a minority ethnic or racial background in these regions requires a comprehensive approach that considers the complex interplay of immigration, diagnostic inequity, and social determinants of health.

摘要

对疑似多发性硬化症的鉴别诊断是基于北美、北欧和澳大拉西亚的数据制定的,重点关注白种人群。多发性硬化症高发地区的少数族裔和少数种族背景的人群在健康的社会决定因素方面受到的负面影响往往比这些地区的白种人更大。更好地了解人口结构的变化、少数族裔或少数种族背景人群的临床特征以及他们所面临的社会挑战,可能有助于在考虑多发性硬化症的诊断时采取公平的临床方法。对于来自北美的北美、北欧和澳大拉西亚的少数族裔和少数种族背景的人群,应考虑视神经脊髓炎、系统性红斑狼疮、神经结节病、感染和脑血管疾病(如高血压)在多发性硬化症的鉴别诊断中。在这些地区,对于少数族裔或少数种族背景的人群,多发性硬化症的诊断需要一种全面的方法,考虑到移民、诊断不公平和健康的社会决定因素的复杂相互作用。

相似文献

1
Differential diagnosis of suspected multiple sclerosis: considerations in people from minority ethnic and racial backgrounds in North America, northern Europe, and Australasia.疑似多发性硬化症的鉴别诊断:北美、北欧和澳大拉西亚少数族裔和种族背景人群的考虑因素。
Lancet Neurol. 2024 Oct;23(10):1050-1062. doi: 10.1016/S1474-4422(24)00288-6.
2
Differential diagnosis of suspected multiple sclerosis: global health considerations.疑似多发性硬化症的鉴别诊断:全球健康考虑因素。
Lancet Neurol. 2024 Oct;23(10):1035-1049. doi: 10.1016/S1474-4422(24)00256-4.
3
Exclusion and inclusion of nonwhite ethnic minority groups in 72 North American and European cardiovascular cohort studies.72项北美和欧洲心血管队列研究中对非白人少数族裔群体的排除与纳入情况。
PLoS Med. 2006 Mar;3(3):e44. doi: 10.1371/journal.pmed.0030044.
4
A systematic review of ethnic minority participation in randomised controlled trials of systemic therapies for gynecological cancers.系统评价少数民族参与妇科癌症系统治疗的随机对照试验。
Gynecol Oncol. 2024 May;184:178-189. doi: 10.1016/j.ygyno.2024.01.052. Epub 2024 Feb 7.
5
Exploring racial and ethnic disparities in the hidradenitis suppurativa patient disease journey: Results from a real-world study in Europe and the USA.探究化脓性汗腺炎患者疾病历程中的种族和民族差异:欧洲和美国一项真实世界研究的结果
J Dermatol. 2024 Dec;51(12):1547-1558. doi: 10.1111/1346-8138.17386. Epub 2024 Oct 14.
6
Enrollment of Older Patients, Women, and Racial and Ethnic Minority Individuals in Valvular Heart Disease Clinical Trials: A Systematic Review.老年患者、女性以及种族和少数民族个体在心脏瓣膜病临床试验中的入组情况:一项系统评价。
JAMA Cardiol. 2023 Sep 1;8(9):871-878. doi: 10.1001/jamacardio.2023.2098.
7
Current opinion: Racial and ethnic health disparities in multiple sclerosis: considering the social determinants of health.当前观点:多发性硬化症中的种族和民族健康差异:关注健康的社会决定因素。
Curr Opin Neurol. 2024 Jun 1;37(3):245-251. doi: 10.1097/WCO.0000000000001264. Epub 2024 Mar 20.
8
Ablation Versus Drug Therapy for Atrial Fibrillation in Racial and Ethnic Minorities.消融与药物治疗在少数民族人群中的心房颤动。
J Am Coll Cardiol. 2021 Jul 13;78(2):126-138. doi: 10.1016/j.jacc.2021.04.092.
9
Overcoming Career Advancement Barriers to Executive Leadership Roles of Nurses From Racial and Ethnic Minority Backgrounds.克服少数族裔背景护士晋升行政领导角色的职业障碍。
Nurs Adm Q. 2024;48(1):71-79. doi: 10.1097/NAQ.0000000000000619.
10
Central Nervous System Idiopathic Inflammatory Demyelinating Disorders in South Americans: A Descriptive, Multicenter, Cross-Sectional Study.南美洲中枢神经系统特发性炎性脱髓鞘疾病:一项描述性、多中心、横断面研究。
PLoS One. 2015 Jul 29;10(7):e0127757. doi: 10.1371/journal.pone.0127757. eCollection 2015.

引用本文的文献

1
Phenotyping Healthcare Use 2-3 Decades Before the First Multiple Sclerosis Demyelinating Event.在首次多发性硬化脱髓鞘事件发生前20至30年的医疗保健使用情况表型分析。
Ann Clin Transl Neurol. 2025 Aug;12(8):1585-1594. doi: 10.1002/acn3.70092. Epub 2025 Jun 12.
2
Real-World Treatment Outcomes in Black, Hispanic, Asian, and White Patients with Multiple Sclerosis Treated with Natalizumab.接受那他珠单抗治疗的黑人、西班牙裔、亚裔和白人多发性硬化症患者的真实世界治疗结果
Drugs Real World Outcomes. 2025 May 30. doi: 10.1007/s40801-025-00495-w.
3
The real-world safety of Ofatumumab: a pharmacovigilance analysis based on the FDA adverse event reporting system.
奥法木单抗的真实世界安全性:基于美国食品药品监督管理局不良事件报告系统的药物警戒分析。
Front Immunol. 2025 Jan 23;16:1515730. doi: 10.3389/fimmu.2025.1515730. eCollection 2025.